Business Description
Medifast Inc
NAICS : 812199
SIC : 7299
ISIN : US58470H1014
Share Class Description:
STU:MDF: Ordinary SharesDescription
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.82 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 698.35 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 8.05 | |||||
| Beneish M-Score | -3.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.6 | |||||
| 3-Year EBITDA Growth Rate | 3 | |||||
| 3-Year EPS without NRI Growth Rate | 1.8 | |||||
| 3-Year FCF Growth Rate | 3.2 | |||||
| 3-Year Book Growth Rate | 11.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.35 | |||||
| 9-Day RSI | 39.5 | |||||
| 14-Day RSI | 37.16 | |||||
| 6-1 Month Momentum % | -53.55 | |||||
| 12-1 Month Momentum % | -63.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.43 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 1.63 | |||||
| Days Inventory | 97.96 | |||||
| Days Payable | 102.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 14.93 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| 3-Year Dividend Growth Rate | 3.1 | |||||
| Forward Dividend Yield % | 20.25 | |||||
| 5-Year Yield-on-Cost % | 36.69 | |||||
| 3-Year Average Share Buyback Ratio | 2.5 | |||||
| Shareholder Yield % | 21.04 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.37 | |||||
| Operating Margin % | 11.79 | |||||
| Net Margin % | 9.27 | |||||
| FCF Margin % | 13.19 | |||||
| ROE % | 54.86 | |||||
| ROA % | 31.33 | |||||
| ROIC % | 99.13 | |||||
| ROC (Joel Greenblatt) % | 177.49 | |||||
| ROCE % | 63.42 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 3.52 | |||||
| PE Ratio without NRI | 3.3 | |||||
| Shiller PE Ratio | 4.56 | |||||
| Price-to-Owner-Earnings | 2.84 | |||||
| PEG Ratio | 0.16 | |||||
| PS Ratio | 0.32 | |||||
| PB Ratio | 1.72 | |||||
| Price-to-Tangible-Book | 1.73 | |||||
| Price-to-Free-Cash-Flow | 2.46 | |||||
| Price-to-Operating-Cash-Flow | 2.36 | |||||
| EV-to-EBIT | 1.78 | |||||
| EV-to-EBITDA | 1.61 | |||||
| EV-to-Revenue | 0.2 | |||||
| EV-to-FCF | 1.55 | |||||
| Price-to-Projected-FCF | 0.2 | |||||
| Price-to-DCF (Earnings Based) | 0.11 | |||||
| Price-to-DCF (FCF Based) | 0.08 | |||||
| Price-to-Median-PS-Value | 0.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.14 | |||||
| Price-to-Graham-Number | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 3.01 | |||||
| Price-to-Net-Cash | 8.37 | |||||
| Earnings Yield (Greenblatt) % | 56.09 | |||||
| FCF Yield % | 40.08 | |||||
| Forward Rate of Return (Yacktman) % | 51.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medifast Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 995.502 | ||
| EPS (TTM) (€) | 8.429 | ||
| Beta | 0.96 | ||
| Volatility % | 42.95 | ||
| 14-Day RSI | 37.16 | ||
| 14-Day ATR (€) | 1.04782 | ||
| 20-Day SMA (€) | 31.927 | ||
| 12-1 Month Momentum % | -63.59 | ||
| 52-Week Range (€) | 29.12 - 98.2 | ||
| Shares Outstanding (Mil) | 10.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medifast Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medifast Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medifast Inc Frequently Asked Questions
What is Medifast Inc(STU:MDF)'s stock price today?
The current price of STU:MDF is €30.46. The 52 week high of STU:MDF is €98.20 and 52 week low is €29.12.
When is next earnings date of Medifast Inc(STU:MDF)?
The next earnings date of Medifast Inc(STU:MDF) is 2024-04-29.
Does Medifast Inc(STU:MDF) pay dividends? If so, how much?
The Dividend Yield %  of Medifast Inc(STU:MDF) is 14.93% (As of Today), Highest Dividend Payout Ratio of Medifast Inc(STU:MDF) was 0.63. The lowest was 0.15. And the median was 0.5. The  Forward Dividend Yield % of Medifast Inc(STU:MDF) is 20.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers